Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Nektar Therapeutics Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$92.2 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 05, 2020	SELL	$15.87 - $23.12 $469,291 - $683,681	-29,571 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$16.91 - $36.27 $178,248 - $382,322	-10,541 Reduced 26.28%	29,571 $539,000
Q2 2019 Aug 08, 2019	BUY	$31.0 - $36.3 $164,362 - $192,462	5,302 Added 15.23%	40,112 $1.43 Million
Q1 2019 Apr 26, 2019	BUY	$31.58 - $46.35 $73,802 - $108,319	2,337 Added 7.2%	34,810 $1.17 Million
Q4 2018 Feb 08, 2019	SELL	$30.43 - $56.65 $39,376 - $73,305	-1,294 Reduced 3.83%	32,473 $1.03 Million
Q3 2018 Nov 13, 2018	BUY	$46.46 - $68.49 $568,252 - $837,701	12,231 Added 56.79%	33,767 $2.06 Million
Q2 2018 Aug 09, 2018	BUY	$46.25 - $104.45 $859,001 - $1.94 Million	18,573 Added 626.83%	21,536 $1.05 Million
Q1 2018 May 02, 2018	BUY	$57.4 - $108.44 $170,076 - $321,307	2,963 New	2,963 $315,000

Others Institutions Holding NKTR

# of Institutions

147

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

Deep Track Capital, LP Greenwich, CT

15.9M
Shares

$16.4 Million
0.76% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$15.6 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$13.5 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

9.4M
Shares

$9.68 Million
0.22% of portfolio
Samlyn Capital, LLC New York, NY

9.2M
Shares

$9.48 Million
0.19% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $193M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account